• SmartestCrowd
    • No organizations
    • No projects
0
0
CCXI Stock Rockets; Amgen Plans $3.7 Billion ChemoCentryx Buyout As Generics Loom | Investor's Business Daily - Investor's Business Daily
8/4/22 at 4:20pm
Organization
Investor's Business Daily
Author
Investor's Business Daily
36 words
0
Comments
The company will pay $52 per share to buy ChemoCentryx, a rare disease-focused firm.
You are the first to view
https://www.investors.com/news/technology/ccxi-stock-rockets-as-amgen-plans-chemocentryx-takeover/
Create an account or login to join the discussion